CMQCC, in partnership with March of Dimes, select hospitals statewide, and community partners are collaborating to promote the use of daily low-dose aspirin for pregnant individuals at risk for preeclampsia. Low-dose aspirin, as recommended by a healthcare provider, is the only known effective solution to prevent preeclampsia.
Preeclampsia is a serious disease during pregnancy, where high blood pressure and other complications can put the baby and pregnant person at risk. It affects about 4% of pregnancies in the United States and accounts for 6% of preterm births. Black birthing individuals are at greater risk for developing preeclampsia, due to heightened experiences of racism, further exacerbating disparities in maternal health outcomes.
- March of Dimes "Learn about Preeclampsia"
- Patient Education Information Sheet "Let's Do Aspirin! To keep baby and you safe from preeclampsia" in English and Spanish
- Patient Scorecard "Should I do aspirin...to keep me and my baby safe?" in English and Spanish
Resources for prenatal healthcare providers
- Findings: U.S. Preventive Task Force "Final Recommendation Preeclampsia Screening"
- Poster: "Prevent Preeclampsia with Low-Dose Aspirin" for use in clinics and waiting rooms in English and Spanish
- Patient Education Information Sheet: "Let's Do Aspirin! To keep baby and you safe from preeclampsia" in English and Spanish
- Patient Scorecard: "Should I do aspirin...to keep me and my baby safe?" in English and Spanish
- Slide Set: Mini Grand Rounds : Low-Dose Aspirin (LDA) Campaign to Reduce Preeclampsia and Related Preterm Birth
- Toolkit for hospitals: CMQCC Hypertensive Disorders of Pregnancy Toolkit (an evidence-based QI toolkit includes a section on low-dose aspirin)
This work is generously funded by the March of Dimes.